Want to join the conversation?
$MYL 2Q15 Call: Our global generic segment generated third-party net sales of just over $2Bil, an increase YoverY of 43% on constant-currency basis. In North America, sales totaled $937MM, up 27% YoverY. Our Legacy business grew by 22%. This growth was contributed by strong performance of sales from new products &higher volumes on existing products
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?